Vijayaraghavan Rajagopalan, Senthilkumar Sivanesan, Roy Anitha, Sheela Durairajan, Geetha Royapuram Veeraragavan, Magesh Anitha
Saveetha Institute of Medical and Technical Sciences, Thandalam, Chennai, Tamil Nadu, India.
SAGE Open Med. 2022 Jul 5;10:20503121221108614. doi: 10.1177/20503121221108614. eCollection 2022.
The objective of the present study was to evaluate the safety and tolerability of autoinjector devices (AIDs) in rabbits by intramuscular (i.m.) administration, using haematological and biochemical markers.
Emergency and mass casualty situations require immediate drug delivery for which AIDs are preferred. The tolerability of amikacin as antibacterial and buprenorphine as analgesic AID has been studied in rats by intraperitoneal administration. In the present study, it was evaluated in rabbits by i.m. administration.
Water-filled glass cartridges (2.3-2.4 mL) were converted to amikacin (106 mg/mL) and buprenorphine (0.128 mg/mL) cartridges. Dual dose AID was used for i.m. administration (1.2 mL). The study was done as a crossover design on 12 rabbits. Initially, three rabbits each were given manually or AID, 57 mg/kg amikacin, and three rabbits each by manual or by AID, 0.07 mg/kg buprenorphine for 7 days. After 1 month, the injections were changed in the rabbits. In the place of manual injection, AID and in the place of amikacin, buprenorphine injection was given. This ensured that all rabbits received 14 injections, 7 manual and 7 AID consisting of 7 amikacin and 7 buprenorphine. 24 h before and 24 h after last drug administrations, blood was withdrawn from ear vein for haematological and biochemical estimations.
The rabbits were healthy, active and no sign of any injection-related changes were observed after administration of amikacin and buprenorphine by manually or by AID. The haematological and biochemical parameters showed similar changes in manual and AID administration of amikacin and buprenorphine.
The present study of amikacin and buprenorphine by AID shows the safety of the device and is recommended for further experimentation. These AIDs are intended for self-administration during emergency and mass causality situation and are suitable for adults and children, as well as farm and pet animals.
本研究的目的是通过肌肉注射,利用血液学和生化指标评估自动注射器装置(AIDs)在兔体内的安全性和耐受性。
紧急情况和大规模伤亡事件需要立即给药,自动注射器装置是首选。已通过腹腔注射在大鼠中研究了阿米卡星作为抗菌药物和丁丙诺啡作为镇痛药物的自动注射器装置的耐受性。在本研究中,通过肌肉注射在兔体内进行了评估。
将装有水的玻璃药筒(2.3 - 2.4 mL)转换为含有阿米卡星(106 mg/mL)和丁丙诺啡(0.128 mg/mL)的药筒。使用双剂量自动注射器装置进行肌肉注射(1.2 mL)。该研究以交叉设计对12只兔进行。最初,每组三只兔分别通过手动或自动注射器装置给予57 mg/kg阿米卡星,每组三只兔分别通过手动或自动注射器装置给予0.07 mg/kg丁丙诺啡,持续7天。1个月后,对兔进行注射更换。用自动注射器装置代替手动注射,用丁丙诺啡注射代替阿米卡星注射。这确保所有兔接受14次注射,7次手动注射和7次自动注射器装置注射,包括7次阿米卡星注射和7次丁丙诺啡注射。在最后一次给药前24小时和给药后24小时,从耳静脉采血进行血液学和生化评估。
兔健康、活跃,通过手动或自动注射器装置给予阿米卡星和丁丙诺啡后,未观察到任何与注射相关的变化迹象。在手动和自动注射器装置给予阿米卡星和丁丙诺啡时,血液学和生化参数显示出相似的变化。
本研究中对自动注射器装置给予阿米卡星和丁丙诺啡的研究表明该装置的安全性,建议进一步试验。这些自动注射器装置旨在用于紧急情况和大规模伤亡事件中的自我给药,适用于成人和儿童,以及农场和宠物动物。